Innovation agency Enterprise Ireland has signed a new alliance with Northwell Health, intended to advance commercialisation activities for Irish life sciences and health tech companies in the US.
Building on a preexisting partnership forged in 2016, the renewed alliance is anticipated to help more Enterprise Ireland-supported companies secure procurement contracts with Northwell Health, gain resources to initiate clinical pilots and trials, and obtain strategic investments through the US health system’s investment fund, Northwell Ventures.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Enterprise Ireland partners with Irish enterprises to help them navigate their development in global markets. In 2024, the innovation agency was determined to be the world’s most active life sciences and healthtech VC in a report by PitchBook, with 60 investments made that year.
Kevin Sherry, Enterprise Ireland’s executive director, said: “Ireland’s life sciences and health tech sector is producing world-class innovation at a remarkable pace and is attracting record VC investment, a testament to the depth and quality of Ireland’s R&D ecosystem.
“Our new strategic alliance with Northwell Health sits at the heart of that ambition, providing significant opportunities for innovative Irish companies to commercialise and co-develop new innovations and enter the US market.”
According to Enterprise Ireland, Northwell is currently engaged in relationships with 18 companies, including healthcare staffing platform provider CliniShift, and telerehabilitation specialist Salaso Health Solutions. The relationships include procurement contracts, clinical trials, and strategic investments.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIn tandem with the new alliance’s signing on 17 March, Northwell also struck a partnership with Irish medtech company Neurent Medical, which has received support from Enterprise Ireland throughout the development of its Neuromark technology for treating chronic rhinitis and other inflammatory sinonasal diseases.
Elaine Brennan, executive director of global strategic partnerships at Northwell Health, commented: “Our International Business Program has proven to be an invaluable gateway for innovative international companies seeking to enter and scale within the US healthcare market.”
“Since 2016, we have provided Enterprise Ireland client companies with direct access to clinical experts across one of America’s largest health systems, resulting in meaningful outcomes including procurement contracts, clinical pilots and trials, and strategic investments from Northwell Ventures.”
